At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Alkaloids; Antiarrhythmics; Small molecules
- Mechanism of Action Muscarinic M3 receptor antagonists; Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 03 Sep 1998 No-Development-Reported for Arrhythmias in Taiwan (Unknown route)
- 05 Nov 1996 New profile
- 05 Nov 1996 Preclinical development for Arrhythmias in Taiwan (Unknown route)